Ovarian cancer

This publication has 15 references indexed in Scilit:

• Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients
  BJOG: An International Journal of Obstetrics and Gynaecology, 1999
• Cancer statistics, 1999
  CA: A Cancer Journal for Clinicians, 1999
• ICON2: randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin, and cisplatin) in women with ovarian cancer
  The Lancet, 1998
• Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
  New England Journal of Medicine, 1996
• Health Insurance and Mortality
  JAMA, 1993
• The Relation between Health Insurance Coverage and Clinical Outcomes among Women with Breast Cancer
  New England Journal of Medicine, 1993
• Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stages III (suboptimal) and IV ovarian cancer: A southwest oncology group study
  Cancer, 1993
• The impact of subspecialty training on the management of advanced ovarian cancer
  Gynecologic Oncology, 1992
• Socioeconomic status and cancer survival.
  Journal of Clinical Oncology, 1991
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958